http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 02 Sep 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/HYTN+Announces+Arrangement+Agreement+to+Facilitate+the+Spin-Out+of+a+Peptide-Focused+Drug+Development+Business/27015866.html <p>VANCOUVER, British Columbia, Sept. 02, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, announces that it has entered into an arrangement agreement with Peptide Development Labs Inc. (“PDL”) dated September 1, 2026 (the “Arrangement Agreement”), pursuant to which HYTN will separate its peptide-focused drug development business centered on the pre-clinical development of a subcutaneous injectable BPC-157 drug candidate for refractory ligament disorders into PDL (the “Arrangement”). HYTN’s Board of Directors formed a special committee, which recommended approving http://www.streetinsider.com/Press+Releases/HYTN+Announces+Arrangement+Agreement+to+Facilitate+the+Spin-Out+of+a+Peptide-Focused+Drug+Development+Business/27015866.html Wed, 02 Sep 2026 08:00:00 -0400 HYTN http://www.streetinsider.com/Globe+Newswire/HYTN+Announces+Arrangement+Agreement+to+Facilitate+the+Spin-Out+of+a+Peptide-Focused+Drug+Development+Business/27015866.html <p>VANCOUVER, British Columbia, Sept. 02, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, announces that it has entered into an arrangement agreement with Peptide Development Labs Inc. (“PDL”) dated September 1, 2026 (the “Arrangement Agreement”), pursuant to which HYTN will separate its peptide-focused drug development business centered on the pre-clinical development of a subcutaneous injectable BPC-157 drug candidate for refractory ligament disorders into PDL (the “Arrangement”). HYTN’s Board of Directors formed a special committee, which recommended approving http://www.streetinsider.com/Globe+Newswire/HYTN+Announces+Arrangement+Agreement+to+Facilitate+the+Spin-Out+of+a+Peptide-Focused+Drug+Development+Business/27015866.html Wed, 02 Sep 2026 08:00:00 -0400 HYTN http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Press+Releases/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html <p>VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, is pleased to announce that its Health Canada Drug Establishment Licence (DEL) has been amended following a comprehensive Good Manufacturing Practices (GMP) inspection of its Kelowna, British Columbia Facility.</p> <p>Under the amended licence, issued by Health Canada, HYTN is now authorized to fabricate, package, and label non-sterile Active Pharmaceutical Ingredients (API) in both solid and non-solid forms, and adds Pharmaceutical Oil as an http://www.streetinsider.com/Globe+Newswire/HYTN+Drug+Establishment+Licence+Expanded+to+Include+Active+Pharmaceutical+Ingredients+and+Pharmaceutical+Oils/26454918.html Thu, 07 May 2026 17:00:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070 http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html <p>VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to announce the successful sale and export of GMP-manufactured live resin vape cartridges, now released for sale in Australia’s regulated medical cannabis market.</p> <p>The shipment included 1,000 one-gram live resin vape cartridges produced as finished goods under Good Manufacturing Practices (GMP). Fully manufactured, packaged, labelled, and released through HYTN’s GMP quality systems, these market-ready cartridges demonstrate HYTN’s capability http://www.streetinsider.com/Press+Releases/HYTN+Successfully+Exports+GMP-Manufactured+Vape+Cartridges/26409791.html Thu, 30 Apr 2026 17:01:00 -0400 85W0 A.17150087 A.50208593 HYTN HYTNF O.00303771 O.02538367 O.49223070